These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 11722323)

  • 1. Post-dexamethasone cortisol correlates with severity of depression before and during carbamazepine treatment in women but not men.
    Osuch EA; Cora-Locatelli G; Frye MA; Huggins T; Kimbrell TA; Ketter TA; Callahan AM; Post RM
    Acta Psychiatr Scand; 2001 Nov; 104(5):397-401. PubMed ID: 11722323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Low-dose (0.5 mg) DST in manic and major depressive episodes: in relation to the severity of symptoms].
    Matsunaga H; Sarai M
    Seishin Shinkeigaku Zasshi; 2000; 102(4):367-98. PubMed ID: 10892305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between plasma cortisol and CSF catecholamines in endogenous depressed dexamethasone nonsuppressors.
    Lu RB; Ho SL; Ho BT; Leu SY; Shian LR; Chen WL
    J Affect Disord; 1986; 10(3):177-84. PubMed ID: 2943770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lithium augmentation increases post-dexamethasone cortisol in the dexamethasone suppression test in unipolar major depression.
    Bschor T; Baethge C; Adli M; Eichmann U; Ising M; Uhr M; Müller-Oerlinghausen B; Bauer M
    Depress Anxiety; 2003; 17(1):43-8. PubMed ID: 12577277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma dexamethasone concentration and cortisol response during manic episodes.
    Cassidy F; Ritchie JC; Carroll BJ
    Biol Psychiatry; 1998 May; 43(10):747-54. PubMed ID: 9606529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Influence of depressive history on biological parameters in major depression].
    Van Wijnendaele R; Hubain P; Dramaix M; Mendlewicz J; Linkowski P
    Encephale; 2002; 28(1):51-8. PubMed ID: 11963343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The dexamethasone suppression test in affective disorders. A review].
    Charles G; Wilmotte J; Mendlewicz J
    Acta Psychiatr Belg; 1982; 82(3):349-62. PubMed ID: 6299064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma dexamethasone concentrations and differential suppression response of cortisol and corticosterone in depressives and controls.
    Holsboer F; Haack D; Gerken A; Vecsei P
    Biol Psychiatry; 1984 Mar; 19(3):281-91. PubMed ID: 6722226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The dexamethasone suppression test and unipolar/bipolar distinctions.
    Zisook S; Janowsky DS; Overall JE; Risch SC
    J Clin Psychiatry; 1985 Nov; 46(11):461-5. PubMed ID: 4055705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The dexamethasone suppression test: an overview of its current status in psychiatry. The APA Task Force on Laboratory Tests in Psychiatry.
    Am J Psychiatry; 1987 Oct; 144(10):1253-62. PubMed ID: 3310667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The dexamethasone suppression test in affective disorder: relationship to clinical and genetic subgroups.
    Mendlewicz J; Charles G; Franckson JM
    Br J Psychiatry; 1982 Nov; 141():464-70. PubMed ID: 7150882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Use of the dexamethasone test in the differential diagnosis of depressive states].
    Nuller IuL; Ostroumova MN; Gordon OI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1986; 86(4):547-51. PubMed ID: 3716705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The dexamethasone suppression test and quantitative cerebral anatomy in depression.
    Coffey CE; Wilkinson WE; Weiner RD; Ritchie JC; Aque M
    Biol Psychiatry; 1993 Mar; 33(6):442-9. PubMed ID: 8490071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dexamethasone suppression test, TRH test and Newcastle II depression rating in the diagnosis of depressive disorders.
    Larsen JK; Bjørum N; Kirkegaard C; Aggernaes H; Krog-Meyer I; Lund-Laursen AM; Mikkelsen PL
    Acta Psychiatr Scand; 1985 May; 71(5):499-505. PubMed ID: 3925727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pretreatment DST and hypothalamic-pituitary-adrenocortical function in depressed patients and comparison groups. A multicenter study.
    Stokes PE; Stoll PM; Koslow SH; Maas JW; Davis JM; Swann AC; Robins E
    Arch Gen Psychiatry; 1984 Mar; 41(3):257-67. PubMed ID: 6367690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of carbamazepine on dexamethasone suppression and sleep electroencephalography in borderline personality disorder.
    De la Fuente JM; Bobes J; Vizuete C; Mendlewicz J
    Neuropsychobiology; 2002; 45(3):113-9. PubMed ID: 11979058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dexamethasone suppression test and the levels of serum growth hormone, plasma vasopressin and plasma homovanillic acid in depressed in- and outpatients.
    Syvälahti E
    Acta Psychiatr Scand; 1985 Feb; 71(2):105-10. PubMed ID: 3976406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dexamethasone suppression test findings in subjects with personality disorders: associations with posttraumatic stress disorder and major depression.
    Grossman R; Yehuda R; New A; Schmeidler J; Silverman J; Mitropoulou V; Sta Maria N; Golier J; Siever L
    Am J Psychiatry; 2003 Jul; 160(7):1291-8. PubMed ID: 12832244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The dexamethasone suppression test and the Children's Depression Inventory in psychiatric disorders in children.
    Woodside DB; Brownstone D; Fisman S
    Can J Psychiatry; 1987 Feb; 32(1):2-4. PubMed ID: 3815250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dexamethasone suppression tests in antidepressant treatment of melancholia. The process of normalization and test-retest reproducibility.
    Greden JF; Gardner R; King D; Grunhaus L; Carroll BJ; Kronfol Z
    Arch Gen Psychiatry; 1983 May; 40(5):493-500. PubMed ID: 6340634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.